You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GYRE Sale Disclosure
Ye Weiguo · SEC Form 4 · Filed Jun 15, 2026
Sale
Calculated transaction value
$17.28K
Ye Weiguo Chief Operating Officer
GYRE
Gyre Therapeutics
GYRE
Transaction date
Jun 11, 2026
Public filing date
Jun 15, 2026
Filing lag
Filed 4 days later
GYRE daily price context
Close on/before transaction
$6.06
Jun 11, 2026
First close after public filing
$5.82
Jun 16, 2026
30-day return after filing
+12.71%
Through Jul 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,800 shares @ $6.17
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001140361-26-025208
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$19.38K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 11, 2026 | $2.1K |
| Gyre Therapeutics, Inc. GYRE Current | Sale | Jun 11, 2026 | $17.28K |
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 11, 2026 | $0 |